Please login to the form below

Not currently logged in
Email:
Password:

multidrug resistant infections

This page shows the latest multidrug resistant infections news and features for those working in and with pharma, biotech and healthcare.

Pfizer launches antibiotic resistance surveillance website

Pfizer launches antibiotic resistance surveillance website

Dr Freda Lewis-Hall, Pfizer ’s chief medical officer, said: “An important aspect for physicians when treating patients is knowledge; knowledge of where certain resistant bacterial infections tend to occur and ... Meanwhile, Pfizer’s new antibiotic

Latest news

  • Pfizer launches new antibiotic Zavicefta in UK and Germany Pfizer launches new antibiotic Zavicefta in UK and Germany

    Pfizer's new antibiotic for multidrug resistant (MDR) infections - Zavicefta - has been launched in the UK and Germany, its first EU markets. ... One of the key roles for the new product is in the treatment of infections with carbapenem-resistant

  • AZ gets EU green light for new antibiotic Zavicefta AZ gets EU green light for new antibiotic Zavicefta

    AZ gets EU green light for new antibiotic Zavicefta. EMA approves combination drug for treatment of multidrug resistant infections. ... AstraZeneca's new antibiotic for multidrug resistant (MDR) infections - Zavicefta - has been approved for marketing in

  • Merck starts pivotal trials of new antibiotic combination Merck starts pivotal trials of new antibiotic combination

    Beta-lactamase inhibitor relebactam is a welcome addition to the late-stage antibiotics pipeline, which remains fairly sparse despite high levels of concern worldwide about multidrug resistant (MDR) infections. ... imipenem), a broad-spectrum carbapenem

  • CHMP backs AZ's 'superbug' antibiotic product CHMP backs AZ's 'superbug' antibiotic product

    AstraZeneca is months away from introducing Zavicefta, its new antibiotic product for multidrug resistant (MDR) infections, in the EU. ... Some CRE infections are resistant to all known antibiotics and according to some reports can contribute to the

  • Roche drops superbug partnership with Polyphor Roche drops superbug partnership with Polyphor

    Roche has opted to discontinue an alliance with Swiss biopharma company Polyphor to develop antibiotics for resistant infections. ... Roche's decision to drop the programme comes at a time of continued anxiety about the threat of multidrug-resistant (MDR)

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics